Bullish Signal: Nifty Correction Nears End; Bet on Banking, Pharma

Market analyst Rohit Srivastava indicates that the Nifty's current correction phase is likely concluding, with the index approaching a critical support level of 23,077. This suggests a potential reversal point for the broader Indian market, shifting sentiment from cautious to optimistic.

This analysis is significant for traders as it provides a potential bottoming signal for the Nifty, offering an entry opportunity for long positions. Identifying sectors like banking, energy, metals, and pharma as strong contenders for a breakout helps in strategic portfolio allocation during an anticipated market upturn.

The banking sector is highlighted for its strength, implying potential positive movement for major banks like HDFC Bank (HDFCBANK), ICICI Bank (ICICIBANK), and State Bank of India (SBIN). Energy stocks such as Reliance Industries (RELIANCE) and ONGC (ONGC), along with metal companies like Tata Steel (TATASTEEL) and Hindalco (HINDALCO), could see renewed buying interest. Pharma stocks like Sun Pharma (SUNPHARMA) and Dr. Reddy's (DRL) are poised for a long-term breakout.

Traders should monitor Nifty's price action around the 23,077 level for confirmation of support. Look for increased volumes in the recommended sectors and positive news flow. Key banking metrics like NIM and asset quality, along with global commodity prices for energy and metals, will be crucial indicators for sustained upside.

• •Market correction may be nearing its end.
• •Nifty approaching a key support zone around 23,077.
• •Banking, energy, and metals sectors show strength.
• •Pharma is poised for a long-term breakout.
• •Investors are advised patience as the market potentially turns upwards.